C153H199Cl3F12N18O16 — CID 160823515
2-(1-acetylpiperidin-4-yl)-1-[(2S)-4-[bis[4-(trifluoromethoxy)phenyl]methyl]-2-tert-butylpiperazin-1-yl]ethanone;2-(1-acetylpiperidin-4-yl)-1-[(2S)-2-tert-butyl-4-[(4-chlorophenyl)-(4-methoxyphenyl)methyl]piperazin-1-yl]ethanone;2-(1-acetylpiperidin-4-yl)-1-[(2S)-2-tert-butyl-4-[(4-chlorophenyl)-pyridin-2-ylmethyl]piperazin-1-yl]ethanone;4-[2-[(2S)-4-[bis[4-(trifluoromethoxy)phenyl]methyl]-2-tert-butylpiperazin-1-yl]-2-oxoethyl]piperidine-1-carboxamide;4-[2-[(2S)-2-tert-butyl-4-[(4-chlorophenyl)-(4-methoxyphenyl)methyl]piperazin-1-yl]-2-oxoethyl]piperidine-1-carboxamide (PubChem CID 160823515) has the molecular formula C153H199Cl3F12N18O16 and a molecular weight of 2880.72 g/mol. Its IUPAC name is 2-(1-acetylpiperidin-4-yl)-1-[(2S)-4-[bis[4-(trifluoromethoxy)phenyl]methyl]-2-tert-butylpiperazin-1-yl]ethanone;2-(1-acetylpiperidin-4-yl)-1-[(2S)-2-tert-butyl-4-[(4-chlorophenyl)-(4-methoxyphenyl)methyl]piperazin-1-yl]ethanone;2-(1-acetylpiperidin-4-yl)-1-[(2S)-2-tert-butyl-4-[(4-chlorophenyl)-pyridin-2-ylmethyl]piperazin-1-yl]ethanone;4-[2-[(2S)-4-[bis[4-(trifluoromethoxy)phenyl]methyl]-2-tert-butylpiperazin-1-yl]-2-oxoethyl]piperidine-1-carboxamide;4-[2-[(2S)-2-tert-butyl-4-[(4-chlorophenyl)-(4-methoxyphenyl)methyl]piperazin-1-yl]-2-oxoethyl]piperidine-1-carboxamide.
| Compound Name | 2-(1-acetylpiperidin-4-yl)-1-[(2S)-4-[bis[4-(trifluoromethoxy)phenyl]methyl]-2-tert-butylpiperazin-1-yl]ethanone;2-(1-acetylpiperidin-4-yl)-1-[(2S)-2-tert-butyl-4-[(4-chlorophenyl)-(4-methoxyphenyl)methyl]piperazin-1-yl]ethanone;2-(1-acetylpiperidin-4-yl)-1-[(2S)-2-tert-butyl-4-[(4-chlorophenyl)-pyridin-2-ylmethyl]piperazin-1-yl]ethanone;4-[2-[(2S)-4-[bis[4-(trifluoromethoxy)phenyl]methyl]-2-tert-butylpiperazin-1-yl]-2-oxoethyl]piperidine-1-carboxamide;4-[2-[(2S)-2-tert-butyl-4-[(4-chlorophenyl)-(4-methoxyphenyl)methyl]piperazin-1-yl]-2-oxoethyl]piperidine-1-carboxamide |
|---|---|
| PubChem CID | 160823515 |
| Molecular Formula | C153H199Cl3F12N18O16 |
| Molecular Weight | 2880.72 g/mol |
| Exact Mass | 2877.42 |
| IUPAC Name | 2-(1-acetylpiperidin-4-yl)-1-[(2S)-4-[bis[4-(trifluoromethoxy)phenyl]methyl]-2-tert-butylpiperazin-1-yl]ethanone;2-(1-acetylpiperidin-4-yl)-1-[(2S)-2-tert-butyl-4-[(4-chlorophenyl)-(4-methoxyphenyl)methyl]piperazin-1-yl]ethanone;2-(1-acetylpiperidin-4-yl)-1-[(2S)-2-tert-butyl-4-[(4-chlorophenyl)-pyridin-2-ylmethyl]piperazin-1-yl]ethanone;4-[2-[(2S)-4-[bis[4-(trifluoromethoxy)phenyl]methyl]-2-tert-butylpiperazin-1-yl]-2-oxoethyl]piperidine-1-carboxamide;4-[2-[(2S)-2-tert-butyl-4-[(4-chlorophenyl)-(4-methoxyphenyl)methyl]piperazin-1-yl]-2-oxoethyl]piperidine-1-carboxamide |
| SMILES | CC(=O)N1CCC(CC(=O)N2CCN(C(c3ccc(Cl)cc3)c3ccccn3)C[C@@H]2C(C)(C)C)CC1.CC(=O)N1CCC(CC(=O)N2CCN(C(c3ccc(OC(F)(F)F)cc3)c3ccc(OC(F)(F)F)cc3)C[C@@H]2C(C)(C)C)CC1.CC(C)(C)[C@H]1CN(C(c2ccc(OC(F)(F)F)cc2)c2ccc(OC(F)(F)F)cc2)CCN1C(=O)CC1CCN(C(N)=O)CC1.COc1ccc(C(c2ccc(Cl)cc2)N2CCN(C(=O)CC3CCN(C(C)=O)CC3)[C@@H](C(C)(C)C)C2)cc1.COc1ccc(C(c2ccc(Cl)cc2)N2CCN(C(=O)CC3CCN(C(N)=O)CC3)[C@@H](C(C)(C)C)C2)cc1 |
| InChI | InChI=1S/C32H39F6N3O4.C31H42ClN3O3.C31H38F6N4O4.C30H41ClN4O3.C29H39ClN4O2/c1-21(42)39-15-13-22(14-16-39)19-28(43)41-18-17-40(20-27(41)30(2,3)4)29(23-5-9-25(10-6-23)44-31(33,34)35)24-7-11-26(12-8-24)45-32(36,37)38;1-22(36)33-16-14-23(15-17-33)20-29(37)35-19-18-34(21-28(35)31(2,3)4)30(24-6-10-26(32)11-7-24)25-8-12-27(38-5)13-9-25;1-29(2,3)25-19-40(16-17-41(25)26(42)18-20-12-14-39(15-13-20)28(38)43)27(21-4-8-23(9-5-21)44-30(32,33)34)22-6-10-24(11-7-22)45-31(35,36)37;1-30(2,3)26-20-34(17-18-35(26)27(36)19-21-13-15-33(16-14-21)29(32)37)28(22-5-9-24(31)10-6-22)23-7-11-25(38-4)12-8-23;1-21(35)32-15-12-22(13-16-32)19-27(36)34-18-17-33(20-26(34)29(2,3)4)28(25-7-5-6-14-31-25)23-8-10-24(30)11-9-23/h5-12,22,27,29H,13-20H2,1-4H3;6-13,23,28,30H,14-21H2,1-5H3;4-11,20,25,27H,12-19H2,1-3H3,(H2,38,43);5-12,21,26,28H,13-20H2,1-4H3,(H2,32,37);5-11,14,22,26,28H,12-13,15-20H2,1-4H3/t27-;28-,30?;25-;2*26-,28?/m11111/s1 |
| InChIKey | SFVVZLLMAFNJFL-GFRZUVALSA-N |
| XLogP | 28.95 |
| TPSA | 339.61 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 22 |
| Rotatable Bonds | 31 |
| Heavy Atoms | 202 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2880.72 |
| LogP ≤ 5 | 28.95 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 22 |